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BACKGROUND: The processes underlying persistence and remission of attention-deﬁcit/hyperactivity disorder
(ADHD) are poorly understood. We examined whether cognitive and neurophysiological impairments on a
performance-monitoring task distinguish between ADHD persisters and remitters.
METHODS: On average 6 years after initial assessment, 110 adolescents and young adults with childhood ADHD
(87 persisters, 23 remitters) and 169 age-matched control participants were compared on cognitive-performance
measures and event-related potentials of conﬂict monitoring (N2) and error processing (error-related negativity and
positivity) from an arrow ﬂanker task with low-conﬂict and high-conﬂict conditions. ADHD outcome was examined
with parent-reported symptoms and functional impairment measures using a categorical (DSM-IV) and a dimensional
approach.
RESULTS: ADHD persisters were impaired compared with controls on all cognitive-performance and event-related
potential measures (all p , .05). ADHD remitters differed from persisters and were indistinguishable from control
participants on the number of congruent (low-conﬂict) errors, reaction time variability, error-related negativity, and
error-related positivity (all p # .05). Remitters did not differ signiﬁcantly from the other groups on incongruent (high-
conﬂict) errors, mean reaction time, and N2. In dimensional analyses on all participants with childhood ADHD, ADHD
symptoms and functional impairment at follow-up were signiﬁcantly correlated with congruent errors, reaction time
variability, and error-related positivity (r 5 .19–.23, p # .05).
CONCLUSIONS: Cognitive and neurophysiological measures of attention-vigilance and error detection distinguished
ADHD remitters from persisters. These results extend our previous ﬁndings with other tasks and indicate that such
measures are markers of remission and candidates for the development of nonpharmacological interventions.
Keywords: ADHD, Cognitive impairments, EEG, Event-related potentials, Persistence, RemissionISShttp://dx.doi.org/10.1016/j.biopsych.2016.06.021The identiﬁcation of cognitive and neural processes underlying
the trajectories of persistence and recovery from childhood-
onset disorders during the transition to adulthood has
the potential to prevent negative long-term outcomes (1,2).
Attention-deﬁcit/hyperactivity disorder (ADHD) is a neurode-
velopmental disorder affecting 5%–6% of children and ado-
lescents worldwide (3,4). ADHD often persists into adulthood,
where the prevalence rate is around 2%–3% (5), with severe
impacts on many aspects of individuals’ lives (6,7). Although in
a proportion of cases ADHD symptoms reduce to subclinical
levels from childhood to adulthood (8), little is known about the
compensatory processes and enduring deﬁcits of ADHD.
It has been proposed that the cognitive processes asso-
ciated with persistence of ADHD across development may be
separate from those linked to the remission of the disorder (9).
However, empirical data to date are inconsistent with regard to
the exact pattern of cognitive impairments that distinguish& 2016 Society of Biological Psychiatry. Publishe
N: 0006-3223 Biologica
SEE COMMENTARYADHD remitters from persisters. Whereas some studies com-
paring ADHD remitters and persisters have linked remission to
better executive function performance (1,10), other studies
have found no differences between ADHD remitters and
persisters in adolescence and adulthood on measures of
executive functions (11–15).
The assessment of neurocognitive processes using cogni-
tive and brain activity data may allow a deeper understanding
of the developmental trajectories of ADHD. Our recent
investigation of adolescents and young adults with childhood
ADHD assessed on a range of cognitive, event-related
potential (ERP), and electroencephalography (EEG) measures
found that ADHD remitters differed from persisters, but not
from control participants, on preparation-vigilance measures
(reaction time variability [RTV], omission errors, ERP activity of
response preparation, and delta and theta activity) and
actigraphic data on movement. Executive-function processesd by Elsevier Inc. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/4.0/).
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span backward, and ERP activity of inhibitory control), instead,
were not sensitive to ADHD persistence or remission, as
ADHD remitters showed an intermediate pattern between
persisters and control participants, without signiﬁcant differ-
ences from either group (14). Further combined investigations
of cognitive and neurophysiological data may aid our under-
standing of the mechanisms underlying ADHD remission and
persistence.
Neurocognitive impairments in ADHD include deﬁcits in
performance monitoring, an essential cognitive ability in goal-
directed behavior to monitor ongoing performance and to
adjust response selection (16–18). The investigation of
performance-monitoring impairments with ERP parameters,
including the N2 and the error-related negativity (ERN) and
positivity (Pe), in individuals with ADHD may provide new
information to elucidate the neurocognitive pathways of
remission. The N2 is a frontocentral stimulus-locked negative
deﬂection mostly observed 200–400 ms after the presentation
of stimuli inducing high conﬂict (such as incongruent stimuli)
and when a correct response is made (17,19). This ERP
reﬂects a conﬂict-monitoring process, as it results from the
conﬂict arising from two competing responses and evaluation
of the correct response (19). When a participant makes an
error, the ERN, a frontocentral response-locked negative
deﬂection at around 0–150 ms is observed, followed by the
Pe, a centroparietal positive enhancement at around 200–400
ms after response (20–22). The ERN is thought to reﬂect
unconscious activity of a generic response-monitoring system
immediately after a mistake is made, whereas the Pe is
thought to represent conscious error processing to adjust
response strategy (23).
In ADHD, N2 attenuation in the ﬂanker task has been
reported in children and adults with ADHD (24–26), although
two smaller studies failed to replicate this ﬁnding (27,28). With
regard to ERN and Pe attenuation in ADHD, a recent meta-
analysis found an overall ERN attenuation in performance-
monitoring tasks (29). Pe attenuations in ADHD samples were
signiﬁcant in Go/NoGo tasks, but not ﬂanker tasks. Yet, data
on these ERPs in individuals with ADHD are overall limited,
and study samples have remained small. Furthermore, studies
have not, to date, investigated the association between
neurophysiological performance monitoring and ADHD persis-
tence and remission. One recent study showed that ERN and
Pe deﬁcits may be improved with motivational incentives or
methylphenidate medication in ADHD groups (30), suggesting
malleability of the error-processing impairments in ADHD.
In the present study, we aimed to extend our recent
ﬁndings (14) by investigating cognitive and neurophysiological
impairments from a performance monitoring task in adoles-
cents and young adults with persistent and remitted ADHD.
We examined ADHD outcome with parent-reported symptoms
and functional impairment measures using both a categorical
(DSM-IV) and a dimensional approach. Based on our previous
results and evidence of potentially malleable neurophysiolog-
ical error processing, we predicted that cognitive measures
underlying nonexecutive processes and ERPs of error proc-
essing (ERN/Pe) would distinguish between ADHD persisters
and remitters and would represent markers of remission. We
further predicted that cognitive indices of executive control924 Biological Psychiatry December 15, 2016; 80:923–932 www.sobpwould not vary with persistence or remission of ADHD.
No formal predictions were made for ERP measures of
conﬂict monitoring (N2), owing to absence of any evidence
suggesting a possible association with remission or persis-
tence of ADHD.METHODS AND MATERIALS
Sample
The sample consists of 279 participants, who were followed
up on average 5.8 years (SD 5 1.1) after initial assessments:
110 had a diagnosis of DSM-IV combined-type ADHD in
childhood (10 sibling pairs and 90 singletons) and 169 were
control participants (76 sibling pairs and 17 singletons) (14,31).
Participants with ADHD were initially recruited from specialized
ADHD clinics (32) and control participants from schools in the
United Kingdom. Information on any diagnosed neurodeve-
lopmental and psychiatric conditions and medication use were
collected through neuropsychiatric screening. Exclusion cri-
teria at both assessments included IQ , 70, autism, epilepsy,
brain disorders, and any genetic or medical disorder associ-
ated with externalizing behaviors that might mimic ADHD.
Other comorbidities were not excluded in order to have an
ADHD sample that is representative of the clinical population.
At follow-up, we excluded six control participants who met
DSM-IV ADHD criteria based on the parent-reported Barkley
Informant Rating Scale (33) and six participants with ADHD
who had missing parent ratings of clinical impairments. Two
participants with childhood ADHD, who did not meet ADHD
symptom criteria but met clinical levels of impairment at
follow-up, were also excluded to minimize heterogeneity in
the sample.
Among those with childhood ADHD, 87 (79%) continued to
meet clinical (DSM-IV) levels of ADHD symptoms and impair-
ment (ADHD “persisters”), whereas 23 (21%) were below the
clinical cut-off (ADHD “remitters”) (31). Among ADHD remit-
ters, 14 displayed $5 items on either the inattention or
hyperactivity/impulsivity symptom domains, but they did not
show functional impairment. ADHD persisters, remitters, and
control participants did not differ in age, but there were
signiﬁcantly more male participants in the remitted group than
in the other two groups, with no female participants among
ADHD remitters (Table 1). Participants attended a single
research session for clinical, IQ, and cognitive-EEG assess-
ments. Almost one-half (47%) of the participants with child-
hood ADHD were being treated with stimulant medication at
follow-up. Those who were on medication scored signiﬁcantly
higher on ADHD symptoms (F 5 11.34, p , .01) and functional
impairment (F 5 5.22, p , .01) than those who were not taking
medication. However, the proportion of participants on med-
ication did not differ between ADHD persisters and remitters
(χ2 5 1.95, p 5 .16). A 48-hour ADHD medication-free period
was required prior to assessments. Three ADHD persisters
(3.4%) were also on antidepressant medication, but for ethical
reasons they were not asked to stop taking them. These
participants were included in all analyses as their exclusion did
not alter the results. Parents of all participants gave informed
consent following procedures approved by the London-Surrey
Borders Research Ethics Committee (09/H0806/58)..org/journal
Table 1. Sample Demographics Divided by Group, With Test for Group Differences
ADHD-P ADHD-R Ctrl p
ADHD-P vs. Ctrl ADHD-P vs. ADHD-R ADHD-R vs Ctrl
p p p
Sex (M:F) 72:15 23:0 129:40 .02a .24 .03a ,.01b
Age, Years, Mean 6 SD 18.27 6 3.03 18.89 6 3.06 18.77 6 2.19 .15 — — —
IQ, Mean 6 SD 96.20 6 15.33 104.57 6 13.63 109.98 6 12.42 ,.01b ,.01b .02a .10
Group differences on sex were tested via chi-square test; group differences on age and IQ were tested with regression models. Group
differences in sex, age, and IQ were previously reported in another paper on this sample (14).
ADHD-P, attention-deﬁcit/hyperactivity disorder persisters; ADHD-R, attention-deﬁcit/hyperactivity disorder remitters; Ctrl, control group;
F, female, M, male.
ap , .05.
bp , .01.
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The Diagnostic Interview for ADHD in adults (DIVA) (34) was
conducted by trained researchers with parents of the ADHD
probands to assess DSM-IV-deﬁned ADHD presence and
persistence. Raw scores for inattention and hyperactivity/
impulsivity symptoms (range 0–9 for each dimension)
were generated for each participant. Evidence of impairment
commonly associated with ADHD was assessed with the
Barkley’s Functional Impairment Scale (33) during interviews
with parents. Each item ranges from 0 (never or rarely) to
3 (very often). Participants were classiﬁed as “affected” at
follow-up if they scored $6 in either the inattention or hyper-
activity/impulsivity domains on the DIVA and $2 on two or
more areas of impairments on the Barkley’s Functional Impair-
ment Scale. We deﬁned ADHD outcome using a categorical
deﬁnition of persistence based on diagnoses, as well as a
dimensional approach based on levels of symptoms of ADHD
and impairments measured as continuous traits.
IQ Assessment
An estimate of IQ was derived with the vocabulary and block
design subtests of the Wechsler Abbreviated Scale of Intelli-
gence (35).
Task
The task was an adaptation of the Eriksen Flanker paradigm
designed to increase cognitive load as used in previous
studies (24,25,36). In each trial, a central black ﬁxation mark
was replaced by a target arrow (a black 18-mm equilateral
triangle). Participants had to indicate whether this arrow
pointed toward the left or right by pressing corresponding
response buttons with their left or right index ﬁngers. Two
ﬂanker arrows identical in shape and size to the target
appeared 22 mm above and below the center of the target
arrow 100 ms prior to each target arrow. Both ﬂankers pointed
in either the same (congruent) or opposite (incongruent)
direction to the target. As such, conﬂict monitoring is maximal
during the incongruent condition. When the target appeared,
both target and ﬂankers remained on the screen for a further
150 ms, with a new trial being presented every 1650 ms. Two
hundred congruent and 200 incongruent trials were arranged
in 10 blocks of 40 trials over 13 minutes. For further details
on the task, see the Supplement. Cognitive-performance
measures of mean reaction time (MRT), RTV (SD of reaction
times), and number of errors (left-right errors occurring whenBiological Psychparticipants chose the wrong left or right response) were
calculated separately for congruent and incongruent
conditions.
Electrophysiological Recording and Processing
The EEG was recorded from a 62-channel DC-coupled record-
ing system (extended 10–20 montage), using a 500-Hz
sampling rate, impedances under 10 kΩ, and the FCz
electrode as the recording reference. The electro-oculograms
were recorded from electrodes above and below the left eye
and at the outer canthi. EEG data were analyzed using Brain
Vision Analyzer 2.0 (Brain Products, Gilching, Germany). Raw
EEG recordings were down-sampled to 256 Hz, rereferenced
to the average of all electrodes (turning FCz into an active
channel), and ﬁltered using Butterworth band-pass ﬁlters
(0.1–30 Hz, 24 dB/octave). All trials were visually inspected
for electrical artifacts or obvious movement, and sections of
data containing artifacts were removed manually. Ocular
artifacts were identiﬁed using the InfoMax independent com-
ponent analysis algorithm (37). Sections of data containing
artifacts exceeding 6100 μV or with a voltage step .50 μV
were automatically rejected. Baseline correction was applied
using the 2300 to 2100 ms pretarget (2200 to 0 ms
preﬂanker) interval.
Analyses of ERPs of performance monitoring were
restricted to incongruent trials, as the task used in this study
is known to elicit strong N2, ERN, and Pe components in high-
conﬂict, but not in low-conﬂict, conditions (24,25,36). Data
were segmented based on 1) stimulus-locked incongruent
trials where a correct response was made and 2) response-
locked (error-related) incongruent trials where an incorrect
response was made. Individual averages were created based
on each condition, requiring $20 clean segments for each
participant. After averaging, the electrodes and latency win-
dows for ERP analyses were selected based on previous
studies (23–25,38), topographic maps, and the grand averages
(Figures 1 and 2). The N2 was measured as maximum negative
peak at the Fz and FCz electrodes between 250 and 450 ms
after target onset. The ERN was deﬁned with respect to the
preceding positivity (PNe, –100 to 50 ms) and measured at
FCz between 0 and 150 ms. This peak-to-peak measure has
proven to be a robust measure of this component (20,23,39)
and was favored over a peak-to-baseline (maximal amplitude)
measure as the former distinguished ADHD from control
participants in independent samples using this version of
the Eriksen Flanker task (24,25,40); it was therefore the idealiatry December 15, 2016; 80:923–932 www.sobp.org/journal 925
Figure 1. Grand average response-
locked event-related potentials of the
error-related negativity (ERN) at the
FCz electrode between 0 and 150
ms (A) and the error-related positivity
(Pe) at the CPz electrode between 150
and 450 ms (B) after an erroneous
response on the incongruent trials for
attention-deﬁcit/hyperactivity disorder
(ADHD) persisters (ADHD-P, in red),
ADHD remitters (ADHD-R, in green),
and control participants (Controls, in
black), with topographic maps.
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further details see the Supplement). The Pe was measured
as maximum positive peak at the CPz electrode between 150
and 450 ms after an erroneous response on incongruent trials.Statistical Analyses
For RTV and errors, we tested overall effects of group (ADHD
persisters, remitters, control participants), condition (congru-
ent, incongruent), and group by condition interaction using
random intercept models in Stata (StataCorp, College Station,
TX) to control for genetic relatedness of the sibling pairs in a
repeated-measures design. A random intercept model was926 Biological Psychiatry December 15, 2016; 80:923–932 www.sobpalso run to test the effect of group, scalp site (Fz, FCz) and
group by site interaction on the N2. ERN and Pe were
analyzed with regression models with dummy variables to
identify overall group effects, controlling for sibling relatedness
with the “robust cluster” command in Stata. Age correlated
signiﬁcantly with several of the cognitive-ERP measures
(Supplemental Table S1) and was therefore included as a
covariate in group analyses. On measures that indicated a
group effect, post hoc regressions were performed. The
majority of our sample consisted of male participants (80%),
and thus primary analyses were performed on the whole
sample without accounting for sex differences. As groups
were not matched on sex (no female in the sample remitted.org/journal
Figure 2. Grand average stimulus-
locked event-related potentials of the
N2 at the Fz and FCz electrodes
between 250 and 450 ms after
incongruent stimuli where a correct
response was made for attention-
deﬁcit/hyperactivity disorder (ADHD)
persisters (ADHD-P, in red), ADHD
remitters (ADHD-R, in green), and
control participants (Controls, in
black), with topographic maps.
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participants (15 ADHD persisters and 41 control participants)
removed. Cohen’s d effect sizes are presented along with
means, SDs, and test statistics for the group analyses
(Table 2), where 0.20 is considered a small effect, 0.50 a
medium effect, and 0.80 a large effect (41). Pearson correla-
tions examined which measures correlated with DIVA ADHD
symptom scores and functional impairment in those with a
childhood ADHD diagnosis, with age and sex included as
covariates.Biological PsychBecause ADHD persisters had lower IQs than remitters
did (Table 1) (14), and higher IQ in childhood was associated
with ADHD remission at follow-up in this sample (31), all
analyses were also rerun controlling for IQ. All cognitive-ERP
measures were skewed and log-transformed to normal.
Three participants (ADHD persisters) were excluded from
the N2 analysis and 39 (13 ADHD persisters [15%], 3 ADHD
remitters [13%], 23 control participants [14%]) from the ERN/
Pe analysis due to having ,20 artifact-free ERP segments,
which is similar to previous studies using this paradigmiatry December 15, 2016; 80:923–932 www.sobp.org/journal 927
Table 2. Descriptive Statistics and Group Comparison on Cognitive-Performance and ERP Measures
Group Comparison Covarying IQ
ADHD-P ADHD-R Ctrl
ADHD-P
vs. Ctrl
ADHD-P
vs.
ADHD-R
ADHD-R
vs. Ctrl
p
ADHD-P
vs. Ctrl
ADHD-P
vs.
ADHD-R
ADHD-R
vs. Ctrl
Mean 6 SD Mean 6 SD Mean 6 SD p d p d p d p d p d p d p
Performance
Congruent
errors
10.89 6 17.26 4.00 6 3.85 4.14 6 8.31 ,.01a .83b ,.01a .75c ,.01a .04 .95 ,.01a .55c ,.01a .60c .01a .09 .89
Incongruent
errors
57.87 6 20.08 56.22 6 20.75 48.87 6 18.02 ,.01a .53c ,.01a .06 .86 .46 .06d ,.01a .32 .01a .06 .98 .37 .11
Congruent
MRT (ms)
355.82 6 60.39 339.586 38.99 336.25 6 33.28 ,.01a .41 ,.01a .28 .23 .11 .63 .28 — — — — — —
Incongruent
MRT (ms)
449.87 6 56.16 441.94 6 33.44 431.68 6 40.75 ,.01a .40 ,.01a .07 .73 .35 .07d .44 — — — — — —
Congruent
RTV (ms)
114.26 6 65.70 83.19 6 28.22 76.24 6 21.67 ,.01a 1.00b ,.01a .61c ,.01a .35 .11 ,.01a .60c ,.01a .42 .04e .14 .25
Incongruent
RTV (ms)
119.31 6 80.64 88.18 6 32.91 76.12 6 22.84 ,.01a .97b ,.01a .47 .04e .50c .02e ,.01a .55c ,.01a .24 .18 .30 .08d
ERPs
N2 at Fz (mV) 27.23 6 3.69 26.91 6 3.61 26.57 6 3.27 .02e .30 .03e .02 .91 .29 .19 .03 .25 .02e .01 .88 .26 .20
N2 at FCz (mV) 25.8 6 3.74 26.26 6 3.57 26.92 6 3.81 .07d .26 .08d .18 .53 .08 .82 .11 — — — — — —
ERN at FCz
(mV)
7.78 6 3.37 9.64 6 4.11 10.08 6 4.51 ,.01a .55c ,.01a .52c .05e .06 .86 ,.01a .37 ,.01a .39 .09d .01 .98
Pe at CPz (mV) 9.36 6 4.23 10.96 6 4.06 11.31 6 4.27 ,.01a .44 ,.01a .44 .05e .02 .88 .03e .32 .03e .36 .06d .06 .79
Data on performance measures were available for the full sample (87 ADHD-P, 23 ADHD-R, and 169 control participants); data on the N2 were
available for 84 ADHD-P, 23 ADHD-R, and 169 control participants; data on the PNe, ERN, and Pe were available for 74 ADHD-P, 20 ADHD-R, and
146 control participants. Overall effects of group, condition (on cognitive-performance measures), and site (on the N2) and interaction effects were
tested with mixed models and reported in Supplemental Table S2. Only group effects were tested on the ERN and Pe, thus regression models
(rather than mixed models) were used. Age was also included as a covariate in all analyses and its effects are not presented here for simplicity, but
are available upon request.
ADHD-P, attention-deﬁcit/hyperactivity disorder persisters; ADHD-R, attention-deﬁcit/hyperactivity disorder remitters; Congruent, congruent
condition; Ctrl, control; d, Cohen’s d effect size; ERN, error-related negativity; ERP, event-related potential; Incongruent, incongruent condition;
MRT, mean reaction time of correct response to targets; p, regression model signiﬁcant testing; Pe, error-related positivity; RTV, reaction time
variability to targets (i.e., SD of reaction time).
ap # .01.
bd . .80, indicating a large effect size.
cd . .50, indicating a medium effect size.
dp # .09.
ep # .05.
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groups.RESULTS
Group Differences
An overall group effect emerged on all cognitive-performance
and ERP measures (Table 2, Figures 1 and 2). Post hoc
analyses showed that ADHD persisters had signiﬁcantly higher
MRT, RTV, number of errors, enhanced N2 (at Fz, but with a
trend for reduction at FCz, pointing to topographic differences,
as shown in Supplemental Figure S1) and reduced ERN and
Pe compared with control participants, with small-to-large
effect sizes. Signiﬁcant differences between ADHD remitters
and persisters emerged on congruent and incongruent RTV,
congruent errors, ERN, and Pe with medium-to-large effect
sizes. ADHD remitters did not differ from persisters on MRT in
either condition, on incongruent errors and N2, with null-to-
small effect sizes. ADHD remitters and control participants928 Biological Psychiatry December 15, 2016; 80:923–932 www.sobpsigniﬁcantly differed on incongruent RTV, with a medium effect
size, and at trend level with small effect sizes for incongruent
errors and incongruent MRT.
Controlling for IQ, group effects on MRT in both conditions
and N2 at FCz were nonsigniﬁcant (Table 2). Differences
between remitters and persisters became nonsigniﬁcant in
incongruent RTV and trends in ERN and Pe. Remitters and
control participants differed at trend level in incongruent RTV,
but not in incongruent errors. Results for other variables
remained unchanged. When repeating the analyses with
female participants removed, the difference between ADHD
persisters (n 5 63) and remitters (n 5 20) became a trend for
the ERN and nonsigniﬁcant for the Pe. Given the small female
sample sizes (n 5 15; of which only n 5 11 had data on ERN
and Pe) and the discrepancy in the size of male and female
groups, sex differences were not directly tested. However, the
effect sizes in the male-only sample (d 5 0.47 for the ERN,
d 5 0.34 for the Pe) were comparable or only slightly reduced
compared with those of the full sample. Remitters signiﬁcantly
differed from control participants on incongruent MRT,.org/journal
Table 3. Pearson Correlations (Two-Tailed) of Cognitive
Performance and ERP Measures With Interview-Based
DIVA ADHD Symptoms and Clinical Impairment Within the
ADHD Group Only (n 5 110)
Controlling for
Age and Sex
Controlling for IQ,
Age, and Sex
ADHD
Symptoms Impairment
ADHD
Symptoms Impairment
Congruent
Errors
.15 .21a .10 .17b
Incongruent
Errors
.07 .03 .05 ,.01
Congruent
MRT (ms)
2.11 ,.01 .07 2.09
Incongruent
MRT (ms)
.05 2.07 2.01 .14
Congruent
RTV (ms)
.21a .13 .15 .12
Incongruent
RTV (ms)
.21a .18b .14 .10
N2 at Fz
(mV)
.04 .18b .04 .18b
N2 at FCz
(mV)
.07 .12 .10 .15
ERN at FCz
(mV)
2.01 2.15 .03 2.11
Pe at CPz
(mV)
2.20a 2.20a 2.20a 2.20a
ADHD, attention-deﬁcit/hyperactivity disorder; Congruent, congru-
ent condition; DIVA, Diagnostic Interview for ADHD in adults; ERN,
error-related negativity; ERP, event-related potential; Incongruent,
incongruent condition; MRT, mean reaction time of correct response
to targets; Pe, error-related positivity; RTV, reaction time variability to
targets (i.e., SD of reaction time).
ap # .05.
bp # .09.
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errors. All other results remained unchanged. For further
details, see the Supplement.
Associations With ADHD Symptoms and Impairments
Among those with childhood ADHD (n 5 110), both ADHD
symptoms and impairment at follow-up signiﬁcantly correlated
with the Pe (Table 3). ADHD symptoms also signiﬁcantly
correlated with RTV in both conditions, and functional impair-
ment correlated with congruent errors and at trend level with
incongruent RTV and N2 at Fz. When IQ was controlled for, the
correlation of ADHD symptoms or impairment with RTV
became nonsigniﬁcant, and the correlation between functional
impairment and congruent errors became a trend (Table 3).DISCUSSION
In this ﬁrst large-scale investigation of cognitive and neuro-
physiological performance monitoring in adolescents and
young adults with ADHD, we found that ADHD remitters had
enhanced cognitive processes of attention-vigilance (RTV and
congruent errors) and neurophysiological error processing
(ERN and Pe) compared with persisters. Attention-vigilance
measures and conscious error processing were alsoBiological Psychassociated with the continuum of ADHD symptoms and
impairment at follow-up. Conversely, measures of executive
control (incongruent errors), speed of processing (MRT), and
neurophysiological conﬂict monitoring (N2) did not distinguish
remitters from persisters, and thus they were not sensitive to
remission or persistence of the disorder. Processes of atten-
tion-vigilance and neurophysiological error processing can be
markers of remission from ADHD and may be sensitive to the
effects of training or compensatory mechanisms.
RTV, measuring intraindividual variability in reaction time,
and number of congruent errors in the low-conﬂict condition
distinguished ADHD remitters from persisters, but not from
control participants, and were also correlated with continuous
ratings of ADHD symptoms and impairment. Impairments in
such measures in the congruent condition of the ﬂanker task
may result from lapses in attention and index attention-
vigilance processes. Neurophysiological measures of error
processing (ERN and Pe) showed the same association with
ADHD remission. Conscious error processing (Pe) also corre-
lated with the continuous ADHD symptoms and functional
impairments at follow-up. Of note, the group differences
observed on this peak-to-peak ERN were likely explained by
the voltage change from the PNe to the negative ERN peak
(see the Supplement). This measure captures the response-
locked oscillatory pattern immediately before and after an error
is made and as such may reﬂect early attentional processes
linked to automatic error detection. Conversely, incongruent
errors in the high-conﬂict condition, likely reﬂecting a failure in
executive control, and MRT in left-right responses at every
trial, likely measuring speed of processing in this task that
induces high cognitive demands, did not distinguish ADHD
remitters from persisters. Similarly, neurophysiological conﬂict
monitoring (N2) did not differ between ADHD groups, poten-
tially indicating suboptimal parallel stimulus processing
regardless of remission or persistence (17,42). Remitters also
showed lower RTV in the incongruent condition compared
with persisters but were still impaired when compared with
control participants. Given the higher levels of executive
control elicited in the incongruent condition, this could result
from joint inﬂuences of both attention-vigilance and executive
processes. Therefore, RTV in the incongruent condition may
be less sensitive to remission than it is in the congruent
condition.
Primary analyses did not control for IQ, as lower-mean IQ in
ADHD samples represents one of multiple cognitive processes
underlying ADHD pathophysiology (43,44), and the etiological
inﬂuences shared between ADHD and IQ are largely separate
from those shared with other cognitive impairments (45–47).
Thus, by removing IQ effects when investigating the relation-
ship between ADHD and cognitive-ERP variables, one may
also control for features of ADHD related to IQ (48,49). In this
sample, ADHD remission was associated with higher IQ
measured both in childhood and at follow-up (14,31). As such,
it may be that higher IQ represents a potential compensatory
mechanism. To test the association between cognitive-ERP
measures and remission or persistence beyond the inﬂuence
of IQ, we also repeated the analyses covarying for IQ. When
controlling for IQ, overall group differences for MRT were
no longer signiﬁcant, suggesting that group differences on
this measure may reﬂect ADHD impairments related to IQ.iatry December 15, 2016; 80:923–932 www.sobp.org/journal 929
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PsychiatryMoreover, remitters were more similar to persisters in some
markers of remission (RTV, ERN, and Pe) when removing the
IQ effects. This further points to an association between
IQ and better cognitive-neurophysiological proﬁles in ADHD
remitters.
The present study extends the ﬁndings in our previous
investigation that used a cued continuous performance test
(CPT-OX), a four-choice reaction time task, and Wechsler
Abbreviated Scale of Intelligence measures of IQ and digit
span (14). Attention-vigilance and error detection showed a
similar pattern to that found in our previous analyses for
preparation-vigilance measures (RTV, omission errors, ERP
activity of response preparation, and delta and theta activity),
whereas executive control (measured by incongruent errors),
speed of processing (MRT for left-right responses), and
conﬂict monitoring (N2) did not distinguish remitters from
persisters, which is similar to measures of inhibition and
working memory in our previous investigation (14). ADHD
remitters showed an intermediate pattern between persisters
and control participants on this latter group of measures: they
showed no signiﬁcant differences from either group on the N2,
but there were trend-level differences from control participants
on incongruent errors and MRT, suggesting that the latter two
measures may potentially represent markers of enduring
deﬁcits. Our ﬁndings align with four recent studies reporting
no differences between ADHD remitters and persisters in
executive control (11–14), but not with two earlier studies that
suggested a link from ADHD remission to better executive
function (1,10). More broadly, our ﬁndings are in line with
evidence for a separation of ADHD neurocognitive impair-
ments into bottom-up and top-down processes supported by
genetically sensitive studies (32,50). Our results are also
consistent with reports of ADHD-sensitive improvement fol-
lowing rewards in RTV and ERPs of error processing
(30,51,52), suggesting that such processes are malleable
and may improve with the additional allocation of cognitive
arousal and motivational incentives in ADHD samples. Future
studies may further characterize the relationship between
ADHD outcome and performance monitoring processes by
using tasks with different ratios of congruent and incongruent
trials, which may produce stronger enhancement of conﬂict
processes (53), potentially coupled with single-trial measures
to examine trial-to-trial adjustments (54).
A limitation of this study is that, despite the large sample
size, the low ADHD remission rate at follow-up resulted in a
relatively small group of remitters. Therefore, we could not rule
out the possibility that some nonsigniﬁcant differences
between remitters and other groups could be due to low
power. However, we observed medium-to-large effect sizes
(d 5 0.44–0.75) between persisters and remitters in measures
representing markers of remission, but small or negligible
effect sizes (d 5 0.02–0.28) in measures not sensitive to
ADHD outcome at follow-up, suggesting this study had
sufﬁcient power to detect the major correlates of remission
with the current sample sizes. Furthermore, when we repeated
the analyses for male participants only, differences between
remitters and persisters in the ERN and Pe were reduced.
However, the small sample of female participants did not allow
a direct examination of sex differences. Future studies that
include a higher number of female participants are needed to930 Biological Psychiatry December 15, 2016; 80:923–932 www.sobpfurther investigate these processes also in females. Finally, our
sample included young adults as well as adolescents, who are
still undergoing rapid cortical maturation. Although we con-
trolled for age in all analyses, future follow-up assessments
with participants having reached adulthood and when more
ADHD participants may have remitted could clarify matters
further.
Overall, we report that attention-vigilance and neurophysio-
logical error processes were impaired in ADHD persisters but
not in remitters and may be sensitive to compensatory
mechanisms in those who remit from the disorder. These
processes may be targets for nonpharmacological interven-
tions or behavioral training aimed at alleviating some of the
long-term outcomes of ADHD. Conversely, cognitive meas-
ures of executive control, speed of processing, and conﬂict
monitoring were not sensitive to ADHD remission/persistence.
Considering the importance of using a broad range of
cognitive and neural measures in investigating the mecha-
nisms underlying neurodevelopmental disorders (2), our cog-
nitive and neurophysiological investigation provides an
improved understanding of the trajectories to ADHD remission
and persistence. Future studies should aim to investigate the
neural sources and neurobiological mechanisms underlying
these markers of remission in order to pave the way toward
the development of new interventions aimed at stimulating
processes that are sensitive to remission to reduce severe
long-term outcomes of the disorder.
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